TOI
Oncology Institute Inc
NASDAQ: TOI · HEALTHCARE · MEDICAL CARE FACILITIES
$4.05
+4.92% today
Updated 2026-05-01
Market cap
$366.69M
P/E ratio
—
P/S ratio
0.73x
EPS (TTM)
$-0.54
Dividend yield
—
52W range
$2 – $5
Volume
1.8M
WallStSmart proprietary scores
45
out of 100
Grade: C
Sell
Investment rating
8.0
Growth
A5.5
Quality
C+2.0
Profitability
F6.7
Valuation
B3/9
Piotroski F-Score
Weak
0.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →205 stocks currently score above 75
Price targets
Analyst target
$7.00
+72.84%
12-Month target
—
—
Intrinsic (DCF)
$13.17
Margin of safety
+80.11%
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $2.17M — positive
+ Revenue growth 41.60% QoQ
+ 80.11% below intrinsic value
+ Debt/equity -2.23x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.94 — distress zone
- Thin margins at -12.10%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $252.48M | $324.24M | $393.41M | $502.73M | $502.73M |
| Net income | $152000.00 | $-83.07M | $-64.66M | $-60.61M | $-7.51M |
| EPS | — | — | — | — | $-0.54 |
| Free cash flow | $-67.28M | $-40.88M | $-30.33M | $-27.79M | $2.17M |
| Profit margin | 0.06% | -25.62% | -16.44% | -12.06% | -12.10% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-16 | KAUSHAL, MOHIT | Sale | 38,433 | $3.50 |
| 2026-04-14 | KAUSHAL, MOHIT | Sale | 57,286 | $3.50 |
| 2026-04-09 | CHERNETT, JOREY | Buy | 20,000 | $3.10 |
Peer comparison
Smart narrative
Oncology Institute Inc trades at $4.05. Our Smart Value Score of 45/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.94, it sits in the distress. TTM revenue stands at $502.73M. with profit margins at -12.10%. Our DCF model estimates intrinsic value at $13.17.
Frequently asked questions
What is Oncology Institute Inc's stock price?
Oncology Institute Inc (TOI) trades at $4.05.
Is Oncology Institute Inc overvalued?
Smart Value Score 45/100 (Grade C, Sell). DCF value $13.17.
What is the price target of Oncology Institute Inc (TOI)?
The analyst target price is $7.00, representing +72.8% upside from the current price of $4.05.
What is the intrinsic value of Oncology Institute Inc (TOI)?
Based on our DCF model, intrinsic value is $13.17, a +80.1% margin of safety versus $4.05.
What is Oncology Institute Inc's revenue?
TTM revenue is $502.73M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
0.94 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.73x
ROE-652.00%
Beta0.20
50D MA$3.09
200D MA$3.43
Shares out0.10B
Float0.06B
Short ratio—
Avg volume1.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—